Subscribe on any major podcast player.
Sam Dribin is the Chief Technology Officer for CureMetrix, an AI company focused on solutions that support radiology.
Sam has a diverse background in technology including Biotech software development with expertise in the technical issues facing healthcare and life science companies and laboratories.
For the last five years, he’s been on the forefront evolving artificial intelligence with solutions that are focused on AI-based mammography to improve cancer detection.
We’ve known Sam and CureMetrix for some time as a customer of Qualio, but today he shares his insight into how AI can impact healthcare such as reducing false-positives and increasing access to healthcare everywhere.
Enjoy!
Show notes:
Music:
keldez